|
ATCC
c2c12 murine skeletal muscle myoblasts ![]() C2c12 Murine Skeletal Muscle Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/c2c12 murine skeletal muscle myoblasts/product/ATCC Average 99 stars, based on 1 article reviews
c2c12 murine skeletal muscle myoblasts - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
murine c2c12 myoblast cells ![]() Murine C2c12 Myoblast Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/murine c2c12 myoblast cells/product/ATCC Average 99 stars, based on 1 article reviews
murine c2c12 myoblast cells - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
c2c12 myoblasts ![]() C2c12 Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/c2c12 myoblasts/product/ATCC Average 99 stars, based on 1 article reviews
c2c12 myoblasts - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
c2c12 myoblast cell line ![]() C2c12 Myoblast Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/c2c12 myoblast cell line/product/ATCC Average 99 stars, based on 1 article reviews
c2c12 myoblast cell line - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
mouse myoblast cell line c2c12 ![]() Mouse Myoblast Cell Line C2c12, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mouse myoblast cell line c2c12/product/ATCC Average 99 stars, based on 1 article reviews
mouse myoblast cell line c2c12 - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
murine c2c12 skeletal muscle myoblasts ![]() Murine C2c12 Skeletal Muscle Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/murine c2c12 skeletal muscle myoblasts/product/ATCC Average 99 stars, based on 1 article reviews
murine c2c12 skeletal muscle myoblasts - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
mouse c2c12 myoblast culture mouse c2c12 myoblasts ![]() Mouse C2c12 Myoblast Culture Mouse C2c12 Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mouse c2c12 myoblast culture mouse c2c12 myoblasts/product/ATCC Average 99 stars, based on 1 article reviews
mouse c2c12 myoblast culture mouse c2c12 myoblasts - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
ATCC
c2c12 murine myoblast ![]() C2c12 Murine Myoblast, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/c2c12 murine myoblast/product/ATCC Average 99 stars, based on 1 article reviews
c2c12 murine myoblast - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
Journal: Bioactive Materials
Article Title: Anisotropic mechanotransductive tissue constructs via brush-assisted bioprinting of microfiber-reinforced composite bioinks
doi: 10.1016/j.bioactmat.2025.12.017
Figure Lengend Snippet: Comparative analysis of conventional and brush-assisted bioprinting on cellular behavior. (a) Schematic illustration of shear stress distribution in normal versus brush-assisted printing. (b) Overview of the brush-assisted printing setup. (c) SEM images of collagen fibrils and fluorescence images showing cell viability (live/dead) and cytoskeletal organization (DAPI/phalloidin) of C2C12 myoblasts. Quantification of (d) cell viability post-printing (n = 4), (e) cell metabolic activity (MTT assay, in situ /day 3/day 7, n = 4), (f) nuclei aspect ratio (n = 180), (g) orientation factor (n = 3), and (h) F-actin–positive area at day 3 (n = 10). (i) Comparing normal and brush-assisted printing the mechanotransduction pathways activated by shear stress and collagen alignment. (j) Heatmap of relative gene expression ( YAP, TAZ, AKT1, PIEZO1, PI3K, and CAPN2 ) after 7 days of culture (n = 4). (k) Agarose gel electrophoresis of PCR products from cells cultured on normal versus brush-printed scaffolds for 7 days. (l) Schematic illustration of blocking mechano-sensing ion channel with GsMTx-4. (m) Relative gene expression levels associated with mechanosensing channel and ca 2+ pathway (n = 5), (n) Hippo pathway (n = 5), (o) PI3K-AKT pathway (n = 5). Student's t-test was applied for two-group comparisons, and one-way ANOVA with Tukey's HSD post-hoc test was used for multiple comparisons. Data are presented as mean ± standard deviation (SD). Statistical significance was set at p < 0.05 (∗), p < 0.01 (∗∗), and p < 0.001 (∗∗∗). Abbreviation: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (cell metabolic activity assay); F-actin, Filamentous actin; PI3K , Phosphoinositide 3-kinase; CAPN2 , Calcium-activated neutral protease 2.
Article Snippet: H9C2 cardiomyoblasts (Korean Cell Line Bank, Seoul, Korea) and
Techniques: Shear, Fluorescence, Activity Assay, MTT Assay, In Situ, Gene Expression, Agarose Gel Electrophoresis, Cell Culture, Blocking Assay, Standard Deviation, Metabolic Assay
Journal: Bioactive Materials
Article Title: Anisotropic mechanotransductive tissue constructs via brush-assisted bioprinting of microfiber-reinforced composite bioinks
doi: 10.1016/j.bioactmat.2025.12.017
Figure Lengend Snippet: Physical and biological evaluation of bioconstructs reinforced with straight (CSP) and coiled (CCP) PCL fibers. (a) Schematic illustration and optical images of flow tests with Col (collagen-only), CSP, and CCP bioinks, in which droplets were tilted at 90° for 10 min. (b) Quantification of droplet outflow (n = 10). Rheological measurements of bioinks: (c) storage modulus (G′) from frequency sweep (n = 3), (d) G′ and G″ from temperature sweep (n = 3), and (e) G′ and G″ under cyclic stress loading (10 and 200 Pa) showing viscoelastic recovery (n = 3). (f) SEM images of CCP constructs highlighting coiled PCL fiber and aligned collagen fibrils. (g) Optical image, live/dead staining, DAPI/phalloidin staining, and orientation factor analysis of C2C12 cells and PCL microfibers. Quantification of (h) cell viability (live/dead, n = 4), (i) F-actin–positive area (n = 20), and (j) metabolic activity (MTT assay, in situ /day 3/day 7, n = 4). Student's t-test was applied for two-group comparisons, and one-way ANOVA with Tukey's HSD post-hoc test was used for multiple comparisons. Data are presented as mean ± standard deviation (SD). Statistical significance was set at p < 0.05 (∗), p < 0.01 (∗∗), and p < 0.001 (∗∗∗).
Article Snippet: H9C2 cardiomyoblasts (Korean Cell Line Bank, Seoul, Korea) and
Techniques: Construct, Staining, Activity Assay, MTT Assay, In Situ, Standard Deviation
Journal: Bioactive Materials
Article Title: Anisotropic mechanotransductive tissue constructs via brush-assisted bioprinting of microfiber-reinforced composite bioinks
doi: 10.1016/j.bioactmat.2025.12.017
Figure Lengend Snippet: In vitro myogenic differentiation of C2C12 cells cultured on Col, CSP and CCP scaffolds. (a) Live/dead staining at in situ , DAPI/phalloidin staining at day 3, and DAPI/ MHC staining at day 14. (b) Quantification of cell viability from live/dead assays (n = 4). (c) Nuclei orientation factor after 7 days of culture (n = 4). (d) Nuclei aspect ratio (n = 20). (e) F-actin positive area (n = 4). (f) Quantification of MHC fusion index (left, n = 5) and MHC maturation rate (right, n = 5). (g) Relative gene expression analysis and (h) agarose gel electrophoresis regarding mechanotransduction-related genes ( CAPN2, PIEZO1, RhoA, YAP, and TAZ ) (n = 4). (i) Western blot analysis of PIEZO1 . (j) Schematic illustrating differentiation progression and major genes involved at each stage. (k) Heatmap and (l) agarose gel electrophoresis of PCR products showing relative expression of myogenic markers ( MYF5, MYOD1, MYOG, MHC, MYH2, and MYH4 ) after 21 days of culture (n = 4). (m) Western blot analysis of MHC . Student's t-test was applied for two-group comparisons, and one-way ANOVA with Tukey's HSD post-hoc test was used for multiple comparisons. Data are presented as mean ± standard deviation (SD). Statistical significance was set at p < 0.05 (∗), p < 0.01 (∗∗), and p < 0.001 (∗∗∗). Abbreviation: MYF5 , Myogenic factor 5; MYOD1 , Myogenic differentiation 1; MYOG , Myogenin; MHC , Myosin heavy chain; MYH2 , Myosin heavy chain 2; MYH4 , Myosin heavy chain 4.
Article Snippet: H9C2 cardiomyoblasts (Korean Cell Line Bank, Seoul, Korea) and
Techniques: In Vitro, Cell Characterization, Cell Culture, Staining, In Situ, Gene Expression, Agarose Gel Electrophoresis, Western Blot, Expressing, Standard Deviation
Journal: Molecular Medicine Reports
Article Title: Veronicastrum sibiricum (L.) Pennell extract alleviates inflammation-induced muscle atrophy through NLRP3 inflammasome regulation and mitochondrial function restoration
doi: 10.3892/mmr.2026.13857
Figure Lengend Snippet: Effects of VSE on inflammation-induced muscle atrophy in C2C12 myotubes. All experiments were carried out after C2C12 myoblasts had differentiated into myotubes for 4 days. C2C12 myotubes were pretreated with 0 (LPS only), 1.25, 2.5 or 5 µg/ml VSE for 3 h and then co-treated with 500 ng/ml LPS for (B, D and E) 24 h and (C) 48 h. Controls received no treatments. (A) C2C12 myotubes were exposed to 0–10 µg/ml VSE for 48 h to assess cytotoxicity. (B) mRNA levels of muscle-specific E3 ubiquitin ligases MuRF1 and atrogin-1 were measured using reverse transcription-quantitative PCR. (C) Giemsa-stained images of C2C12 myotubes showing changes in relative fiber width after treatment. CON, untreated control; LPS, 500 ng/ml; 1.25, 2.5 and 5, co-treatment with LPS (500 ng/ml) and VSE at the indicated concentrations (µg/ml). Analysis was performed using ImageJ (National Institutes of Health). Scale bar, 100 µm. Western blot analysis of (D) MuRF1, MaFbx and MyHC protein levels, and (E) phosphorylated Akt and Foxo3a, including membrane images and semi-quantitative analysis using ImageJ. All data are presented as the mean ± SD of triplicate results and statistical analysis was carried out using one-way ANOVA with Tukey's post hoc test. ## P<0.01 and #### P<0.0001 vs. control group; *P < 0.05, **P < 0.01, *** P < 0.001, ****P < 0.0001 vs. LPS-treated group. MuRF1, muscle-specific RING finger protein 1; MaFbx, muscle atrophy F-box protein; MyHC, myosin heavy chain; CON, control; LPS, lipopolysaccharide; VSE, Veronicastrum sibiricum seed extract; p-, phosphorylated; ns, not significant.
Article Snippet:
Techniques: Ubiquitin Proteomics, Reverse Transcription, Real-time Polymerase Chain Reaction, Staining, Control, Western Blot, Membrane
Journal: Molecular Medicine Reports
Article Title: Veronicastrum sibiricum (L.) Pennell extract alleviates inflammation-induced muscle atrophy through NLRP3 inflammasome regulation and mitochondrial function restoration
doi: 10.3892/mmr.2026.13857
Figure Lengend Snippet: VSE downregulates the NLRP3 inflammasome. C2C12 myotubes were pretreated with VSE at 0 (LPS only), 1.25, 2.5 and 5 µg/ml for 3 h and then co-treated with 500 ng/ml LPS for 24 h. Controls received no treatments. (A) mRNA expression levels of NLRP3 , the NLRP3 inflammasome initiator, were analyzed using reverse transcription-quantitative PCR. (B) Protein expression levels of factors associated with the NLPR3 pathway, a major pyroptosis pathway, were analyzed using western blotting and ImageJ. All data are presented as the mean ± SD of triplicate results and statistical analysis was carried out using one-way ANOVA with Tukey's post hoc test. #### P<0.0001, ### P<0.001, ## P<0.01 vs. control; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 vs. LPS treatment. NLRP3, NLR family pyrin domain containing 3; GSDMD, gasdermin-D; LPS, lipopolysaccharide; VSE, Veronicastrum sibiricum seed extract.
Article Snippet:
Techniques: Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Western Blot, Control
Journal: Molecular Medicine Reports
Article Title: Veronicastrum sibiricum (L.) Pennell extract alleviates inflammation-induced muscle atrophy through NLRP3 inflammasome regulation and mitochondrial function restoration
doi: 10.3892/mmr.2026.13857
Figure Lengend Snippet: VSE reduces the secretion of proinflammatory cytokines. C2C12 myotubes were pretreated with VSE at 0 (LPS only), 1.25, 2.5 and 5 µg/ml for 3 h and then co-treated with 500 ng/ml LPS for 24 h. Controls received no treatments. (A) mRNA expression levels of the proinflammatory cytokines TNF-α and IL-1β were analyzed using reverse transcription-quantitative PCR. (B) Protein expression levels of the proinflammatory cytokines TNF-α and IL-1β in the supernatant of C2C12 myotube cultures were analyzed using ELISA. All data are presented as the mean ± SD of triplicate results and statistical analysis was carried out using one-way ANOVA with Tukey's post hoc test. #### P<0.0001 vs. control; ***P<0.001, ****P<0.0001 vs. LPS treatment. A450, absorbance at 450 nm; LPS, lipopolysaccharide; VSE, Veronicastrum sibiricum seed extract.
Article Snippet:
Techniques: Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay, Control
Journal: Molecular Medicine Reports
Article Title: Veronicastrum sibiricum (L.) Pennell extract alleviates inflammation-induced muscle atrophy through NLRP3 inflammasome regulation and mitochondrial function restoration
doi: 10.3892/mmr.2026.13857
Figure Lengend Snippet: VSE exerts antioxidant effects in C2C12 myotubes. C2C12 myotubes were pretreated with 0 (LPS only), 1.25, 2.5 and 5 µg/ml VSE for 3 h and then co-treated with 500 ng/ml LPS for 24 h. (A) Protein expression levels of antioxidant-related factors HO-1, Nrf2 and Keap1, and mitochondrial metabolism-related factor PGC-1α were analyzed using western blotting. (B) Images (left) were obtained under a fluorescence microscope to investigate the generation of mitochondrial ROS using ImageJ (right). Scale bar, 100 µm. All data are presented as the mean ± SD of triplicate results, and statistical analysis was carried out using one-way ANOVA with Tukey's post hoc test. # P<0.05, ## P<0.01, #### P<0.0001 vs. control; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 vs. LPS treatment. LPS, lipopolysaccharide; VSE, Veronicastrum sibiricum seed extract; ROS, reactive oxygen species; HO-1, heme oxygenase-1; Nrf2, nuclear factor erythroid 2-related factor 2; Keap1, kelch like ECH associated protein 1; PGC-1α, peroxisome proliferator-activated receptor γ coactivator 1α; CON, control.
Article Snippet:
Techniques: Expressing, Western Blot, Fluorescence, Microscopy, Control
Journal: Molecular Medicine Reports
Article Title: Veronicastrum sibiricum (L.) Pennell extract alleviates inflammation-induced muscle atrophy through NLRP3 inflammasome regulation and mitochondrial function restoration
doi: 10.3892/mmr.2026.13857
Figure Lengend Snippet: VSE exerts protective effects on mitochondrial function, reducing functional impairment under inflammatory conditions. C2C12 myotubes were pretreated with 0 (LPS only), 1.25, 2.5 and 5 µg/ml VSE for 3 h and then co-treated with 500 ng/ml LPS for 24 h. (A) Protein expression levels of the mitochondrial dynamics-related OXPHOS genes, including CI-CV, were analyzed using western blotting. (B) JC-1 staining was carried out to assess the mitochondrial membrane potential. Representative images of JC-1 fluorescence (red/green) were analyzed using ImageJ (National Institutes of Health). Scale bar, 25 µm. All data are presented as the mean ± SD of triplicate results and statistical analysis was carried out using one-way ANOVA with Tukey's post hoc test. ## P<0.01, #### P<0.0001 vs. control; *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 vs. LPS treatment. LPS, lipopolysaccharide; VSE, Veronicastrum sibiricum seed extract; CI-CV, complexes I–V; OXPHOS, oxidative phosphorylation system; CON, control.
Article Snippet:
Techniques: Functional Assay, Expressing, Western Blot, Staining, Membrane, Fluorescence, Control, Phospho-proteomics
Journal: Journal of Advanced Research
Article Title: Exercise improves hypobaric hypoxia-induced skeletal muscle dysfunction via Sirt1-Mediated myotube and mitochondrial remodeling
doi: 10.1016/j.jare.2025.08.022
Figure Lengend Snippet: Hypobaric hypoxia-induces skeletal muscle dysfunction: characterized by decreased muscle mass and impaired physical performance. (A) The schematic of the experimental setup for the 45-day chronic hypobaric hypoxia murine model. (B) Following 45-day hypobaric hypoxia exposure, mice exhibited reduced four-limb grip strength compared to normoxia controls. n = 5–7/group. (C) Bars represent mean running time on a motorized treadmill. n = 8/group. (D) Bars represent mean rotarod test time on a rotarod latency. n = 10/group. (E) Measurements of muscle tetanic contraction show reduced force in the hypobaric hypoxia group. n = 13–15/group. (F) Representative TA muscles from indicated mice. TA muscle weight was normalized to body mass after hypobaric hypoxia exposure. n = 7/group. (G) Representative haematoxylin and eosin (H&E) staining of TA muscle sections and quantification of CSA. Scale bar: 50 μm. n = 3/group. (H) Representative images of MyHC immunofluorescence of C2C12 cells under control and hypoxia. Measurements of myotube diameter. Scale bar: 50 μm. n = 100 myotubes per condition. (I) Immunoblot analysis and quantification of protein expression in hypoxic C2C12 cells using the indicated antibodies. n = 6/group. * p < 0.05; * *p < 0.01; *** p < 0.001. Unpaired two-tailed t -test compared two groups. Two-way ANOVA was employed for comparisons involving experimental factors with more than two levels.
Article Snippet:
Techniques: Muscles, Staining, Immunofluorescence, Control, Western Blot, Expressing, Two Tailed Test
Journal: Journal of Advanced Research
Article Title: Exercise improves hypobaric hypoxia-induced skeletal muscle dysfunction via Sirt1-Mediated myotube and mitochondrial remodeling
doi: 10.1016/j.jare.2025.08.022
Figure Lengend Snippet: Chronic hypobaric hypoxia exposure impairs the mitochondrial function of skeletal muscle. (A) GO analysis of TA muscle proteomes from normoxia and hypobaric hypoxia groups, profiled by LC-MS/MS. n = 6/group. (B) Heatmap analysis of mitochondrial-related proteins identified by proteomics. (C) Immunoblot analysis and quantification of OXPHOS complexes in TA muscle lysates using the Total OXPHOS Rodent Antibody Cocktail. n = 6/group. (D) Mitochondrial DNA content in TA muscle assessed by qPCR (primers: mitochondria-encoded mtDNA vs. Nuclear-encoded Rbm15). n = 3/group. (E) Mitochondrial membrane potential in C2C12 cells under control and hypoxia using MitoTracker® Deep Red FM. Quantification of the average optical density of MitoTracker. Scale bar: 50 μm/100 μm. (F) Immunoblot analysis and quantification of OXPHOS complexes in C2C12 cells. n = 4/group. * *p < 0.01; *** p < 0.001. Unpaired two-tailed t -test compared two groups. Two-way ANOVA was employed for comparisons involving experimental factors with more than two levels. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Article Snippet:
Techniques: Liquid Chromatography with Mass Spectroscopy, Western Blot, Membrane, Control, Two Tailed Test
Journal: Journal of Advanced Research
Article Title: Exercise improves hypobaric hypoxia-induced skeletal muscle dysfunction via Sirt1-Mediated myotube and mitochondrial remodeling
doi: 10.1016/j.jare.2025.08.022
Figure Lengend Snippet: E3 ubiquitin ligase facilitates degradation of the NAD + -dependent deacetylase Sirt1 under hypoxic conditions. (A) The GO enrichment and pathway analysis of TA muscle proteomes. (B) Immunoblot analysis and quantification of muscle-inhibitory factor expression in TA muscle. n = 6/group. (C) The atrogenes expression level in TA muscle assessed by qPCR. n = 3/group. (D) Immunoblot analysis and quantification of Trim63 in C2C12 cells. n = 6/group. (E) The atrogenes expression level in C2C12 cells assessed by qPCR. n = 3/group. (F) Immunoblot analysis and quantification of Sirt1 expression in TA muscle and C2C12 cells. n = 6/group. (G) Immunoprecipitation analysis of Sirt1 ubiquitination upon co-transfection with Ub-K48 plasmids in C2C12 cells. After 48 h hypoxia exposure, cells were treated with 10 μM MG132 for 24 h. (H) Immunoblot analysis of the expression of Nedd4 and Mdm2 in the whole cell lysates (WCL) of C2C12 cells. (I) Immunoprecipitation analysis of the interaction between E3 ubiquitin ligases and Sirt1 after hypoxic stimulation. * *p < 0.01; *** p < 0.001. Unpaired two-tailed t -test compared two groups. Two-way ANOVA was employed for comparisons involving experimental factors with more than two levels.
Article Snippet:
Techniques: Ubiquitin Proteomics, Histone Deacetylase Assay, Western Blot, Expressing, Immunoprecipitation, Cotransfection, Two Tailed Test
Journal: Journal of Advanced Research
Article Title: Exercise improves hypobaric hypoxia-induced skeletal muscle dysfunction via Sirt1-Mediated myotube and mitochondrial remodeling
doi: 10.1016/j.jare.2025.08.022
Figure Lengend Snippet: Overexpression of Sirt1 attenuates hypoxia-induced myotube atrophy and mitochondrial dysfunction. (A) Immunoblot analysis and quantification of Sirt1 in C2C12 cells transfected with pLV3-CMV-Sirt1 (OE-Sirt1) or empty vector. Myotubes were cultured under control or hypoxia conditions for 72h. n = 5/group. (B) Representative images of MyHC immunofluorescence in C2C12 cells infected with pLV3-CMV-Sirt1 or empty vector under control or hypoxia conditions. Scale bar: 100 μm. Measurements of myotube diameter. n = 100 myotubes per condition. (C) Immunoblot analysis and quantification of Trim63 and Myogenin in C2C12 cells transfected with the indicated constructs. n = 5–6/group. (D) Representative images of mitochondrial membrane potential in myotubes transfected with the indicated constructs using JC-10. Scale bar: 100 μm. Quantification of the ratio of JC-10 aggregates to monomers, i.e., the ratio of red to green fluorescence. n = 3/group. (E) Representative images and quantification of ROS levels in myotubes transfected with the indicated constructs using the DHE probe. Scale bar: 100 μm. n = 3/group. (F) Mitochondrial DNA content and ATP production in C2C12 cells transfected with the indicated constructs. n = 3/group. (G) Graphical representation of oxygen consumption rates (OCR) and ATP production in treated cells is shown. n = 3/group. (H) Immunoblot analysis and quantification of mitochondrial-related protein in C2C12 cells transfected with the indicated constructs. n = 4/group. (I) Immunoblot analysis and quantification of PGC-1α expression in TA muscle and C2C12 cells. n = 5–6/group. (J) Immunoblot analysis and quantification of PGC-1α in C2C12 cells transfected with the indicated constructs. n = 5/group. (K) Immunoprecipitation using PGC-1α antibody and immunoblot analysis of the indicated proteins. * p < 0.05; * *p < 0.01; *** p < 0.001. Unpaired two-tailed t -test compared two groups. One-way ANOVA was used for comparisons involving more than two groups. Two-way ANOVA was employed for comparisons involving experimental factors with more than two levels. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Article Snippet:
Techniques: Over Expression, Western Blot, Transfection, Plasmid Preparation, Cell Culture, Control, Immunofluorescence, Infection, Construct, Membrane, Fluorescence, Expressing, Immunoprecipitation, Two Tailed Test
Journal: Journal of Advanced Research
Article Title: Exercise improves hypobaric hypoxia-induced skeletal muscle dysfunction via Sirt1-Mediated myotube and mitochondrial remodeling
doi: 10.1016/j.jare.2025.08.022
Figure Lengend Snippet: Exercise-mimetic stimulation activates myotube function improvement via Sirt1-PGC-1α/FoxO3a in C2C12 cells. (A) C2C12 myotubes were treated with the AMPK activator AICAR (0.25 mM) for 12 h, then exposed to hypoxia for 72 h. Immunoblot analysis and quantification of Sirt1 and p-AMPK in C2C12 cells were performed. n = 6/group. (B) Representative images of MyHC immunofluorescence in C2C12 cells treated with AICAR under control or hypoxia conditions and measurements of myotube diameter. Scale bar: 100 μm. n = 100 myotubes per condition. (C) Immunoblot analysis and quantification of Trim63 in C2C12 cells treated with AICAR under control or hypoxia conditions. n = 6/group. (D) Representative images of mitochondrial membrane potential in myotubes treated with AICAR under control or hypoxia using JC-10. Scale bar: 100 μm. Quantification of the ratio of JC-10 aggregates to monomers. n = 3/group. (E) Representative images of ROS levels and quantification of the average optical density of DCFH-DA in myotubes treated with AICAR. Scale bar: 100 μm. n = 3/group. (F) Mitochondrial DNA content (n = 6/group) and ATP production in C2C12 cells treated with AICAR(n = 3/group). (G) The redox status of myotubes treated with AICAR was characterized by the ratio of NAD + /NADH. n = 3/group. (H) Graphical representation of OCR and ATP production in treated cells is shown. n = 3/group. (I) Immunoblot analysis and quantification of PGC-1α in C2C12 cells treated with AICAR. n = 6/group. (J) Immunoprecipitation using PGC-1α antibody and immunoblot analysis of the indicated proteins were performed. (K) Immunoblot analysis and quantification of FoxO3a in C2C12 cells treated with AICAR. n = 6/group. (L) Immunoprecipitation using FoxO3a antibody and immunoblot analysis of the indicated proteins were performed. * p < 0.05; * *p < 0.01; *** p < 0.001. Unpaired two-tailed t -test compared two groups. One-way ANOVA was used for comparisons involving more than two groups. Two-way ANOVA was employed for comparisons involving experimental factors with more than two levels.
Article Snippet:
Techniques: Western Blot, Immunofluorescence, Control, Membrane, Immunoprecipitation, Two Tailed Test
Journal: Journal of Cachexia, Sarcopenia and Muscle
Article Title: Deubiquitinase YOD1 Inhibition Suppresses DEX‐ and Denervation‐Induced Muscle Atrophy Through MAFbx Destabilization
doi: 10.1002/jcsm.70300
Figure Lengend Snippet: Effects of YOD1 silencing on DEX‐induced muscle atrophy in differentiated C2C12 myotubes. (a, b) C2C12 myotubes transfected with siRNA of each OTU family gene were treated with DEX for 48 h. Immunofluorescence (IF) was performed using an Alexa Fluor 488‐conjugated MYH antibody, and nuclei were stained with DAPI (a). Protein levels were determined using western blotting (b). (c–f) C2C12 myotubes transfected with control or YOD1 siRNA were treated with DEX for 48 h. Cells were fixed and stained with Giemsa (c). IF was performed using an Alexa Fluor 546‐conjugated MYH antibody, and nuclei were stained with DAPI (d). Protein (e) and mRNA (f) levels were determined using western blotting and qPCR, respectively. # p < 0.01 compared to the control. ** p < 0.01 compared to DEX.
Article Snippet:
Techniques: Transfection, Immunofluorescence, Staining, Western Blot, Control
Journal: Journal of Cachexia, Sarcopenia and Muscle
Article Title: Deubiquitinase YOD1 Inhibition Suppresses DEX‐ and Denervation‐Induced Muscle Atrophy Through MAFbx Destabilization
doi: 10.1002/jcsm.70300
Figure Lengend Snippet: YOD1 deubiquitinases and stabilizes MAFbx. (a) C2C12 myotubes were transfected with control or YOD1 siRNA and then treated with 20 μg/mL of cycloheximide (CHX) for the indicated durations. (b) C2C12 myotubes were transfected with control or YOD1 siRNA and treated with 0.25 μM of MG132, followed by DEX treatment for 12 h. (c) To analyse the ubiquitination of endogenous MAFbx, C2C12 myotubes were co‐transfected with control or YOD1 siRNA in the presence of HA‐Ub and treated with 0.25 μM of MG132, followed by DEX treatment for 24 h. Ubiquitination of endogenous MAFbx was detected using the ubiquitination assay. (d,e) C2C12 myotubes were transfected with vector, GFP‐YOD1 WT or GFP‐YOD1 C160S plasmid and then treated with DEX (d) or 20 μg/mL of CHX (e) for the indicated durations. (f) C2C12 myoblasts were co‐transfected with vector, GFP‐YOD1 WT or GFP‐YOD1 C160S plasmid in the presence of HA‐Ub and FLAG‐MAFbx and treated with MG132 for 12 h. Ubiquitination of exogenous MAFbx was detected using the ubiquitination assay. The band intensity of MAFbx was analysed using ImageJ.
Article Snippet:
Techniques: Transfection, Control, Ubiquitin Proteomics, Plasmid Preparation
Journal: Journal of Cachexia, Sarcopenia and Muscle
Article Title: Deubiquitinase YOD1 Inhibition Suppresses DEX‐ and Denervation‐Induced Muscle Atrophy Through MAFbx Destabilization
doi: 10.1002/jcsm.70300
Figure Lengend Snippet: YOD1 interacts with MAFbx and removes polyubiquitin chains at K48 of MAFbx. (a) C2C12 myotubes were treated with or without DEX for 48 h. Cell lysates were immunoprecipitated with an anti‐MAFbx antibody, followed by immunoblotting (IB) with anti‐YOD1 or anti‐MAFbx antibodies. (b) C2C12 myoblasts were co‐transfected with vector, GFP‐YOD1 WT, or GFP‐YOD1 C160S in the presence of FLAG‐MAFbx. Interactions were demonstrated using IP. (c) C2C12 myoblasts were co‐transfected with vector, GFP‐YOD1 WT, GFP‐YOD1 ΔZn, or GFP‐YOD1 ΔUBX in the presence of FLAG‐MAFbx (left panel). C2C12 myoblasts were co‐transfected with vector, FLAG‐MAFbx WT, FLAG‐MAFbx ΔF‐box, FLAG‐MAFbx ΔNSL2, FLAG‐MAFbx ΔLZ, or FLAG‐MAFbx c‐terminal in the presence of GFP‐YOD1 WT (right panel). Interactions were demonstrated using IP. (d) C2C12 myoblasts were transfected with vector, FLAG‐MAFbx WT, FLAG‐MAFbx K29R, FLAG‐MAFbx K48R, or FLAG‐MAFbx K267R and then treated with 20 μg/mL of CHX for the indicated durations. The band intensity of FLAG was analysed using ImageJ. (e, f) C2C12 myoblasts were co‐transfected with vector, FLAG‐MAFbx WT, FLAG‐MAFbx K29R, FLAG‐MAFbx K48R or FLAG‐MAFbx K267R in the presence of control or YOD1 siRNA. The protein level (e) and ubiquitination of exogenous MAFbx (f) was measured using western blotting and ubiquitination assay, respectively.
Article Snippet:
Techniques: Immunoprecipitation, Western Blot, Transfection, Plasmid Preparation, Control, Ubiquitin Proteomics
Journal: Journal of Cachexia, Sarcopenia and Muscle
Article Title: Deubiquitinase YOD1 Inhibition Suppresses DEX‐ and Denervation‐Induced Muscle Atrophy Through MAFbx Destabilization
doi: 10.1002/jcsm.70300
Figure Lengend Snippet: Effect of G5 on DEX‐induced muscle atrophy in C2C12 myotubes. (a–d) C2C12 myotubes were treated with G5, followed by DEX for 48 h. The cells were fixed and stained with Giemsa stain (a). IF was performed using an Alexa Fluor 546‐conjugated MYH antibody, and nuclei were stained with DAPI (b). Protein (c) and mRNA (d) levels were determined using western blotting and qPCR, respectively. # p < 0.01 compared to control. * p < 0.05 compared to DEX.
Article Snippet:
Techniques: Staining, Giemsa Stain, Western Blot, Control
Journal: Research
Article Title: Doping-Engineered Proangiogenic Nanozymes Orchestrate Ischemic Tissue Regeneration via Cytoprotection and Revascularization
doi: 10.34133/research.1260
Figure Lengend Snippet: Cu-doped Prussian blue (CuPB) nanozymes protect C2C12 myoblasts and H9c2 cardiomyocytes from H 2 O 2 -induced oxidative injury. (A and B) Representative fluorescence images and quantification of intracellular reactive oxygen species (ROS) in H 2 O 2 -injured C2C12 cells after Prussian blue (PB) or CuPB treatment, detected using the 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) probe. Scale bar: 50 μm. n = 5. (C and D) Representative terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining images and quantification of apoptotic C2C12 cells following H 2 O 2 injury with PB or CuPB treatment. Scale bar: 50 μm. n = 5. (E) Quantitative real-time polymerase chain reaction (qRT-PCR) analysis of apoptosis-related genes ( Bcl2 , Caspase3 , Caspase9 , and Bax ) in C2C12 cells after different treatments. n = 3. (F and G) Representative fluorescence images and quantification of intracellular ROS in H 2 O 2 -injured H9c2 cells after PB or CuPB treatment, detected using the DCFH-DA probe. Scale bar: 50 μm. n = 5. (H and I) Representative TUNEL staining images and quantification of apoptotic H9c2 cells following H 2 O 2 injury with PB or CuPB treatment. Scale bar: 50 μm. n = 5. (J) qRT-PCR analysis of apoptosis-related gene expression ( Bcl2 , Caspase3 , Caspase9 , and Bax ) in H9c2 cells after different treatments. n = 5.
Article Snippet: The rat cardiomyocyte cell line (H9c2) was obtained from Procell Life Science & Technology Co., Ltd. (China), and the
Techniques: Fluorescence, End Labeling, TUNEL Assay, Staining, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Gene Expression
Journal: Physiological Reports
Article Title: Synthetic estrogen and progestin effects on the myogenic program following damage in C2C12 murine myoblasts
doi: 10.14814/phy2.70886
Figure Lengend Snippet: (a) Representative images of C2C12 myotubes 6 days after differentiation in vehicle (VEH), OC1, OC2, OC3, and OC4 formulations. Myotubes were stained with desmin (green) and DAPI (blue). (b, d, f) Myotube diameter (um) of vehicle, EE, progestin, and OC formulations after 6 days of differentiation. (c, e, g) Myonuclear index of vehicle, EE, progestin and OC formulations after 6 days of differentiation. Values are presented as median lines and interquartile range (boxes) ± maximum and minimum values (whiskers), with + representing the mean. Statistical comparisons were performed using a one‐way ANOVA. p ‐value indicates a significant difference from vehicle (VEH).
Article Snippet:
Techniques: Staining